-
Recent Posts:
Recent Comments:
Latest PLoG Posts
- New DataCite / ORCID Integration Tool in Work In Progress
- Opportunistic pathogens evolve mostly harmlessly in healthy humans in Work In Progress
- Open for microbiology: PLOS Biology at ASM 2013 in Work In Progress
- Reconnecting with Food. Essential for our health. in Work In Progress
- This Week in PLOS NTDs and PLOS Pathogens: Targeting Schistosome Receptors; the Secret Life of Glycoproteins; New Strategies Against TB; RRV Viral Entry Mediation in Rhesus Monkeys; and More in Work In Progress
You may also be interested in:
Click to go to this PLOS Medicine collection
Blog Archives
Cancer Care’s “Culture of Excess”
Category: cancer, Cost-Effectiveness Analysis, Healthcare
Tagged biomarkers, cancer, cancer care, cancer cost, complex adaptive systems, European Multidisciplinary Cancer Congress, FiercePharma, incremental cost-effectiveness ratios, moral hazard, Richard Sullivan, The Huffington Post, The Lancet Oncology
3 Comments
Jessica Wapner is a freelance writer focused mainly on biomedical issues. Her work is published in Scientific American, The New York Times, Slate, Science, Nature Medicine, and elsewhere. Her first book, The Philadelphia Chromosome is forthcoming from The Experiment in May 2013. 
jessicawapner:
mellor_dan (Dan Mellor)
RodTims (Rodney F. Tims)
FoxChaseCancer (Fox Chase Cancer Ctr)
aragornfischer (Charles Fischer)
daisydeplume (Daisy de Plume)
heatheranneh (Heather Henderson)